Noelia Galiano-Castillo1, Angelica Ariza-García2, Irene Cantarero-Villanueva1, Carolina Fernández-Lao1, Lourdes Díaz-Rodríguez3, Manuel Arroyo-Morales4. 1. Physical Therapy Department, Instituto Investigación Biosanitaria (IBS), University of Granada, Granada, Spain. 2. Physical Therapy Department, Instituto Investigación Biosanitaria (IBS), University of Granada, Granada, Spain; University Hospital San Cecilio, Health Andalusian Service, Avda. Madrid s/n, 18071 Granada, Spain. 3. Nursing Department, Instituto Investigación Biosanitaria (IBS), University of Granada, Granada, Spain. 4. Physical Therapy Department, Instituto Investigación Biosanitaria (IBS), University of Granada, Granada, Spain. Electronic address: marroyo@ugr.es.
Abstract
PURPOSE: One out of five cancer survivors suffer from depression after oncology treatment. The aim of this study was to examine the relationship between depression and quality of life (QoL), cancer-related symptoms, physical activity level, health-related fitness, and salivary flow rate in breast cancer survivors. METHOD: 108 breast cancer survivors in the year after the conclusion of treatment were included in this cross-sectional study. Demographic and clinically relevant information, cancer-related fatigue (Piper Fatigue Scale), QoL (QLQ-Br23 module), pain intensity VAS scale, salivary flow rate, physical activity level (Minnesota Leisure Time Physical Activity Questionnaire), and health-related fitness were assessed in all participants. Depressed mood was measured with the Profile of Mood States (POMS) Depression subscale. RESULTS: Significant positive correlations between depressed mood and fatigue, systemic side effects, perceived shoulder pain, and breast-arms symptoms (r ranged between .57 and .28, P < .01) were found. In addition, significant negative correlations between depressed mood and body image, future perspective, force handgrip, and physical activity level (r ranged between -.41 and -.19; p < .05) were found. Regression analyses revealed that cancer-related fatigue, physical activity level, systemic side effects, and body image were significant predictors of depressed mood, and when combined, they explained 39.6% of the variance in depressed mood. CONCLUSIONS: Cancer-related fatigue, physical activity level, and QoL partially explain the variability of depressed mood in breast cancer survivors. This paper facilitates a better understanding of the relationship between depressed mood and possible factors associated with it.
PURPOSE: One out of five cancer survivors suffer from depression after oncology treatment. The aim of this study was to examine the relationship between depression and quality of life (QoL), cancer-related symptoms, physical activity level, health-related fitness, and salivary flow rate in breast cancer survivors. METHOD: 108 breast cancer survivors in the year after the conclusion of treatment were included in this cross-sectional study. Demographic and clinically relevant information, cancer-related fatigue (Piper Fatigue Scale), QoL (QLQ-Br23 module), pain intensity VAS scale, salivary flow rate, physical activity level (Minnesota Leisure Time Physical Activity Questionnaire), and health-related fitness were assessed in all participants. Depressed mood was measured with the Profile of Mood States (POMS) Depression subscale. RESULTS: Significant positive correlations between depressed mood and fatigue, systemic side effects, perceived shoulder pain, and breast-arms symptoms (r ranged between .57 and .28, P < .01) were found. In addition, significant negative correlations between depressed mood and body image, future perspective, force handgrip, and physical activity level (r ranged between -.41 and -.19; p < .05) were found. Regression analyses revealed that cancer-related fatigue, physical activity level, systemic side effects, and body image were significant predictors of depressed mood, and when combined, they explained 39.6% of the variance in depressed mood. CONCLUSIONS:Cancer-related fatigue, physical activity level, and QoL partially explain the variability of depressed mood in breast cancer survivors. This paper facilitates a better understanding of the relationship between depressed mood and possible factors associated with it.
Authors: Suzanna Maria Zick; Justin Colacino; Maria Cornellier; Tohfa Khabir; Katie Surnow; Zora Djuric Journal: Breast Cancer Res Treat Date: 2016-12-02 Impact factor: 4.872
Authors: Andrea A Cohee; Timothy Stump; Rebecca N Adams; Shelley A Johns; Diane Von Ah; Kathleen Zoppi; Betsy Fife; Patrick O Monahan; David Cella; Victoria L Champion Journal: Qual Life Res Date: 2016-02-16 Impact factor: 4.147
Authors: Kerri M Winters-Stone; Esther L Moe; Cynthia K Perry; Mary Medysky; Rodney Pommier; John Vetto; Arpana Naik Journal: Support Care Cancer Date: 2017-09-30 Impact factor: 3.603
Authors: Angela Mifsud; Melissa J Pehlivan; Paul Fam; Maddison O'Grady; Annamiek van Steensel; Elisabeth Elder; Jenny Gilchrist; Kerry A Sherman Journal: Health Psychol Behav Med Date: 2021-05-21
Authors: R Lobefaro; S Rota; L Porcu; C Brunelli; S Alfieri; E Zito; I Taglialatela; M Ambrosini; A Spagnoletti; M Zimatore; G Fatuzzo; F Lavecchia; C Borreani; G Apolone; F De Braud; M Platania Journal: ESMO Open Date: 2022-03-31
Authors: Vânia Tie Koga Ferreira; Almir Vieira Dibai-Filho; Alessandra Kelly de Oliveira; Cid André Fidelis de Paula Gomes; Elizabete Santos Melo; Ana Maria de Almeida Journal: J Phys Ther Sci Date: 2015-05-26
Authors: Juan Ignacio Arraras; Jose Juan Illarramendi; Esteban Salgado; Susana de la Cruz; Gemma Asin; Ana Manterola; Berta Ibañez; Uxue Zarandona; Miguel Angel Dominguez; Ruth Vera Journal: Contemp Oncol (Pozn) Date: 2016-06-14